Venus Medtech (Hangzhou) Inc.
www.venusmedtech.comVenus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China.
Read more
Venus Medtech (Hangzhou) Inc. is a leading transcatheter heart valve medical device player in China in terms of implantation volume in 2018. The Company’s self-developed product, VenusA-Valve, is the first transcather aortic heart valve replacement (“TAVR”) product approved by the National Medical Products Administration ("NMPA") and commercialized in China.
Read more
Country
City (Headquarters)
Hangzhou
Industry
Employees
501-1000
Founded
2009
Social
Employees statistics
View all employeesPotential Decision Makers
Senior Vice President Sales and Marketing and Founder of Icardiology Uk
Email ****** @****.comPhone (***) ****-****Chief Operations Officer and Chief Technology Officer
Email ****** @****.comPhone (***) ****-****Senior Director of Operations
Email ****** @****.comPhone (***) ****-****Quality Assurance Specialist
Email ****** @****.comPhone (***) ****-****
Technologies
(8)
Reach decision makers at Venus Medtech (Hangzhou) Inc.
Free credits every month!
Venus Medtech (Hangzhou) Inc. FAQ
Hangzhou, China
Medical Equipment Manufacturing
